The AMH Test and Ovarian Reserve: What Your Result Really Means
Few numbers cause as much unnecessary distress as a low AMH result. A woman gets a report with a figure on it, searches the internet, reads the phrase "diminished ovarian reserve", and concludes she cannot have children. In most cases that conclusion is simply wrong. The AMH test is genuinely useful, but it answers a narrower question than most people think, and understanding exactly what it measures — and what it does not — changes how you should react to your result.
What AMH Is and What It Measures
Anti-Müllerian hormone is produced by the small developing follicles in the ovaries. The more of these small follicles a woman has, the higher her AMH. So the test is, in effect, a headcount of the eggs remaining in the reserve pool.
Its practical advantages are real:
It can be taken on any day of the cycle, unlike day 2–3 FSH.
It is relatively stable from month to month.
It predicts how the ovary will respond to stimulation drugs better than any other single test.
It is usually interpreted alongside the antral follicle count, an ultrasound count of visible small follicles. The two together give a much better picture than either alone.
"AMH counts eggs. It does not grade them. That single distinction explains almost every misunderstanding about this test."
What AMH Cannot Tell You
This is the part that gets lost, and it matters more than the number itself.
AMH does tell you
AMH does not tell you
Roughly how many eggs remain in the pool
Whether those eggs are chromosomally normal
How the ovaries are likely to respond to IVF stimulation
Whether you can conceive naturally this month
Whether a strong or weak response should be planned for
Whether your tubes are open or your partner's sperm is normal
A rough indication of how close menopause may be
The exact age at which you will reach menopause
The critical point: egg quality is determined mainly by age, not by AMH. A woman of thirty with a low AMH has fewer eggs, but the ones she has are still thirty-year-old eggs, with a thirty-year-old's chance of being chromosomally normal. A woman of forty-two with a reassuringly high AMH has plenty of eggs, but they are forty-two-year-old eggs. That is why age remains the strongest predictor of outcome, as explained in IVF success rate by age.
A low AMH is not a diagnosis of infertility. Many women with low AMH conceive naturally. What a low result does mean is that the window is likely to be shorter than average, so it is an argument for acting sooner rather than for giving up.
How to Read the Result
Laboratories report AMH in different units, and reference ranges vary between assays, so always interpret your result against the range printed on your own report rather than a figure found online. Broadly, results fall into these bands.
Band
What it suggests
Implication for treatment
Very high
Often polycystic ovaries; many small stalled follicles
Strong response likely; stimulation must be gentle to avoid hyperstimulation
Normal for age
Reserve appropriate to age
Standard stimulation protocol expected to work well
Low for age
Fewer eggs remaining than typical
Fewer eggs likely at collection; do not delay treatment
Very low
Significantly diminished reserve
Individualised protocols; realistic counselling; sometimes donor eggs discussed
In polycystic ovary syndrome, AMH is characteristically high and should not be read as a sign of superior fertility — it reflects stalled follicles. This is covered in our guide to PCOS and fertility.
What Lowers AMH
Age — the dominant factor by far.
Genetics and family history. If your mother had an early menopause, your own timeline may be earlier.
Chemotherapy and pelvic radiotherapy. Fertility preservation should be discussed before cancer treatment begins; our oncology department raises this with younger patients.
Smoking, which is associated with earlier ovarian ageing.
Certain autoimmune and genetic conditions, including fragile X premutation and Turner mosaicism.
Severe endometriosis affecting the ovaries.
Hormonal contraception can temporarily lower the reading, so mention it when your sample is taken.
Low vitamin D has been associated with lower readings in some studies.
Who Should Have the Test
Women being assessed for infertility, as part of the standard workup
Before planning IVF, to choose the stimulation protocol and dose
Women considering egg freezing or delaying pregnancy
Before cancer treatment, when fertility preservation is being discussed
Women with a family history of early menopause
Women who have had ovarian surgery
Women with irregular cycles, alongside other hormone tests
It is less useful as a general screening test for women not currently trying to conceive and not planning treatment, because a result on its own rarely changes what they should do — and frequently causes anxiety out of proportion to its meaning.
What to Do If Your AMH Is Low
The instinct is to search for something that will raise the number. Be sceptical of anything promising that. What genuinely helps is a change of strategy, not a supplement.
Do not delay. This is the single most important response. Low reserve means fewer eggs and, usually, a shorter window. Time is the resource you are short of.
Complete the rest of the workup. AMH is one test. Tubal status and semen analysis matter just as much — see the HSG test and male infertility.
Stop smoking entirely, and limit alcohol.
Correct thyroid function, vitamin D and blood sugar.
Discuss individualised stimulation. Low-reserve patients often do better with tailored protocols than with maximum doses.
Ask about donor eggs if your specialist raises it. It is a conversation, not a verdict, and knowing the option exists reduces pressure rather than adding to it.
The most encouraging fact about low AMH: in IVF it predicts how many eggs will be collected, but it is a poor predictor of whether an individual embryo will implant. Women with low reserve who do produce a good embryo have live birth chances driven largely by their age, not by their AMH.
Anti-Müllerian hormone is produced by the small developing follicles in the ovaries, so the test is effectively a headcount of the eggs remaining in the reserve pool. It can be taken on any day of the cycle, is relatively stable month to month, and predicts how the ovaries will respond to stimulation drugs better than any other single test. It is usually interpreted alongside an ultrasound antral follicle count.
No. AMH counts eggs; it does not grade them. Many women with low AMH conceive naturally. Egg quality, which determines whether an embryo is chromosomally normal, is driven mainly by age rather than by AMH. What a low result does indicate is that the reproductive window is likely to be shorter than average, which is an argument for seeking advice and starting treatment sooner rather than for giving up.
No treatment or supplement reliably raises AMH in a way that increases the number of eggs available, and claims to the contrary should be treated sceptically. What can be done is to stop smoking, correct thyroid function, vitamin D and blood sugar, avoid unnecessary ovarian surgery, and above all not delay treatment. The response to a low AMH is a change of strategy and timing, not a search for a number-raising remedy.
In polycystic ovary syndrome the ovaries contain many small follicles that have begun developing but stalled before releasing an egg. Because each of these produces AMH, the total level is high. It reflects the number of stalled follicles rather than better fertility. It does warn the fertility team that the ovaries may respond strongly to stimulation, which matters for planning an IVF cycle and avoiding ovarian hyperstimulation.
Any day. Unlike FSH, which must be measured on day two or three of the cycle, AMH remains relatively stable throughout, which is one of its main practical advantages. Do mention if you are taking hormonal contraception, as this can temporarily lower the reading, and note that reference ranges differ between laboratories and assays, so interpret your result against the range printed on your own report.
Women being investigated for infertility, women planning IVF so the stimulation protocol can be chosen, those considering egg freezing or delaying pregnancy, women about to start cancer treatment where fertility preservation is being discussed, those with a family history of early menopause, women who have had ovarian surgery, and women with irregular cycles. It is less useful as a general screening test for women not currently trying to conceive.